Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | TDP2 | O95551 | 1/20 | 0.52 |
| ▸ | NSD2 | O96028 | 1/20 | 0.52 |
| ▸ | ABL1 | P00519 | 1/20 | 0.52 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.52 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30447750 | 1.00 | MEN1 (0.52) | MEN1KMT2ATDP2NSD2ABL1 | |
| SCHEMBL12879746 | 0.76 | ALDH1A1 (0.54) | MEN1KMT2ATDP2NSD2ABL1 | |
| SCHEMBL11867527 | 0.76 | KDM4E (0.63) | MEN1KMT2AGAASMN1; SMN2KDM4E | |
| SCHEMBL28387699 | 0.75 | CA9 (0.44) | MEN1KMT2ATDP2NSD2ABL1 | |
| SCHEMBL13495402 | 0.73 | CYP2D6 (0.50) | MEN1KMT2ATDP2NSD2ABL1 | |
| SCHEMBL710689 | 0.73 | ERCC1 (0.62) | MEN1KMT2ATDP2TDP1KDM4E | |
| SCHEMBL29361703 | 0.73 | ERCC1 (0.62) | MEN1KMT2ATDP2TDP1KDM4E | |
| SCHEMBL1410 | 0.73 | ERCC1 (0.62) | MEN1KMT2ATDP2TDP1KDM4E | |
| SCHEMBL14884702 | 0.72 | KDM4E (0.74) | MEN1KMT2ASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL8244207 | 0.72 | SMN1; SMN2 (0.48) | MEN1KMT2ATDP2NSD2ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119638565-A | Method for preparing benzoic acid by oxidizing toluene at room temperature | 中山大学 | 2025-03-18 | — | — | CN | claimed |
| CN-111393397-B | Preparation method of 2, 5-furandicarboxylic acid | 中国科学院大连化学物理研究所 | 2022-04-29 | — | — | CN | claimed |
| CN-119638565-A | Method for preparing benzoic acid by oxidizing toluene at room temperature | 中山大学 | 2025-03-18 | — | — | CN | disclosed |
| WO-2023211710-A1 | METAL-FREE PROCESS FOR HYDROGEN PEROXIDE PRODUCTION | PORTLAND STATE UNIVERSITY (US) | 2023-11-02 | — | — | WO | disclosed |
| CN-112358380-B | Synthesis method of 4- (4' -alkylcyclohexyl) cyclohexanol | 惠泽化学科技(濮阳)有限公司 | 2023-03-31 | — | — | CN | disclosed |
| CN-111393397-B | Preparation method of 2, 5-furandicarboxylic acid | 中国科学院大连化学物理研究所 | 2022-04-29 | — | — | CN | disclosed |
| CN-112358380-A | Synthesis method of 4- (4' -alkylcyclohexyl) cyclohexanol | 惠泽化学科技(濮阳)有限公司 | 2021-02-12 | — | — | CN | disclosed |
| CN-112110820-A | Method for producing higher-valent iodine compound | 帝斯曼知识产权资产管理有限公司 | 2020-12-22 | — | — | CN | disclosed |
| CN-109553566-B | Anti-counterfeiting material with adjustable imaging waveband and preparation method and application thereof | 北京化工大学 | 2020-05-01 | — | — | CN | disclosed |
| US-20080312430-A1 | Method of Preparing or Synthesizing Polyazamacrocycle Derivatives | THERAPHARM GMBH (CH) | 2008-12-18 | — | — | US | disclosed |
| EP-1812453-A1 | METHOD OF PREPARING OR SYNTHESIZING POLYAZAMACROCYCLE DERIVATIVES | Therapharm GmbH (CH) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006045546-A1 | METHOD OF PREPARING OR SYNTHESIZING POLYAZAMACROCYCLE DERIVATIVES | THERAPHARM GMBH (CH) | 2006-05-04 | — | — | WO | disclosed |
| US-6297403-B1 | OXIDATION OF A (DI)ARYL METHANE OR METHYLENE DERIVATIVE IN PRESENCE OF AN AMINE OXIDE OR HYDROXYAMINE DERIVATIVE MEDIATOR; BY-PRODUCT INHIBITION | Consortium für elektrochemische Industrie GmbH (DE) | 2001-10-02 | — | — | US | disclosed |
| US-6187170-B1 | SYSTEM FOR THE ELECTROCHEMICAL CLEAVAGE OF COMPOUNDS WHICH INCLUDES A MEDIATOR AND AT LEAST TWO ELECTRODES FOR THE ELECTROCHEMICAL ACTIVATION OF THE MEDIATOR | Consortium für elektrochemische Industrie GmbH (DE) | 2001-02-13 | — | — | US | disclosed |
| US-6169213-B1 | REACTING A HETEROARYL METHANOL WITH AN OXIDANT AND A MEDIATOR CONTAINING AMINO OXIDE GROUP TO FORM HETEROARYL ALDEHYDE OR A HETEROARYL KETONE | Consortium f{umlaut over (u)}r elektrochemische Industrie GmbH (DE) | 2001-01-02 | — | — | US | disclosed |
| US-6069282-A | REACTION OF VINYL-, ALKYNYL- OR ARYL-METHANOLS WITH THE AID OF A MEDIATOR AND AN OXIDANT, WHEREIN THE MEDIATOR IS SELECTED FROM THE GROUP OF THE ALIPHATIC, CYCLOALIPHATIC, HETEROCYCLIC OR AROMATIC NO OR NOH CONTAINING COMPOUNDS | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 2000-05-30 | — | — | US | disclosed |
| US-6023000-A | Process for the preparation of aldehydes and ketones | Consortium fur elektrochemisch Industrie GmbH (DE) | 2000-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312430-A1 | Method of Preparing or Synthesizing Polyazamacrocycle Derivatives | POLI, PARP1, DHPS | MEN1 585/4885KMT2A 2284/4885TDP2 2315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.